Regeneron's antibody cocktail gets FDA emergency green light


The Food and Drug Administration on Saturday issued an emergency use authorization for Regeneron's antibody cocktail, a treatment that was given to President Trump in October after he tested positive for COVID-19. Trump credited the cocktail for aiding his recovery.
For now, the authorization applies only to high-risk patients — people over the age of 65 or those who have underlying conditions — and the treatment is meant to be administered in the early stages of an infection; it has not been authorized for patients hospitalized with COVID-19 or those who require oxygen therapy.
Demand is likely to outpace supply with infections rising rapidly across the U.S., but Regeneron said it hopes to have enough doses for 80,000 patients by the end of November, 200,000 by the first week in January, and 300,000 by the end of January.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The cocktail consists of two monoclonal antibodies that target the spike protein the coronavirus uses to enter cells. A similar therapy developed by Eli Lilly was granted an emergency use by the FDA earlier this month. Read more at Bloomberg and CNN.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
The IDF's manpower problem
The Explainer Israeli military's shortage of up to 12,000 troops results in call-up for tens of thousands of reservists
-
Quiz of The Week: 16 – 22 August
Quiz Have you been paying attention to The Week's news?
-
Can Soho House get its edge back?
Talking Point The private members' club has lost its exclusive appeal – but a £2 billion buy-out could offer a fresh start
-
Texas declares end to measles outbreak
Speed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agency
Speed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year high
Speed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC